Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mechanical thrombectomy plus umbilical cord blood mononuclear cell microtransplantation for acute intracranial large vessel occlusion
ChiCTR2100048023Phase 4Not yet recruiting
- Sponsor
- Liaocheng City People's Hospital
- Start
- Jul 2021
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of umbilical cord blood mononuclear cells in ischemic stroke and Large vessel occlusion (LVO) (2 arms), sponsored by Liaocheng City People's Hospital. Primary endpoint: 90-day modified Rankin Scale score. Planned start Jul 2021; status: not yet recruiting.
02
Drugs
umbilical cord blood mononuclear cells
03
Conditions
ischemic strokeLarge vessel occlusion (LVO)
Beyond the preview
Go deeper on ChiCTR2100048023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100048023.